Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Apogee Therapeutics, Inc. Common Stock Share Price

APGE

NMQ

$68.93

-$1.34

(-1.91%)

Industry: Biotechnology Sector: Health Care

Apogee Therapeutics, Inc. Common Stock Analyst Forecast

Overview Returns Financials Ratios News FAQs

Apogee Therapeutics, Inc. Common Stock Share Price Chart

Apogee Therapeutics, Inc. Common Stock Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$4.80B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

682.57K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.43

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$26.2 L

$84.56 H

$68.93

About Apogee Therapeutics, Inc. Common Stock, Common Stock

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Apogee Therapeutics, Inc. Common Stock Stock Returns

Time Frame	APGE	Sector	S&P500
1-Week Return	1.39%	1.07%	0.74%
1-Month Return	-14.35%	1.46%	1.28%
3-Month Return	10.09%	3.51%	3.6%
6-Month Return	93%	15.29%	7.31%
1-Year Return	107.16%	7.7%	11.97%
3-Year Return	313.35%	21.02%	72.07%

Time Frame	APGE	Sector	S&P500
1-Week Return	105.40%	74.19%	46.88%
1-Month Return	-84.81%	19.29%	16.74%
3-Month Return	47.68%	15.02%	15.42%
6-Month Return	279.36%	33.44%	15.38%
1-Year Return	107.16%	7.70%	11.97%
3-Year Return	60.49%	6.57%	19.83%

Apogee Therapeutics, Inc. Common Stock Financials

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	189.00K	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	-	-	(189.00K)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-18900000,"profit":false}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	30.73M	93.00M	216.87M	[{"date":"2022-12-31","value":14.17,"profit":true},{"date":"2023-12-31","value":42.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(30.73M)	(93.00M)	(216.87M)	[{"date":"2022-12-31","value":-3072700000,"profit":false},{"date":"2023-12-31","value":-9300300000,"profit":false},{"date":"2024-12-31","value":-21687000000,"profit":false}]
Total Non-Operating Income/Expense	(18.12M)	18.04M	69.48M	[{"date":"2022-12-31","value":-26.07,"profit":false},{"date":"2023-12-31","value":25.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(39.78M)	(83.98M)	(182.13M)	[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-8398500000,"profit":false},{"date":"2024-12-31","value":-18212800000,"profit":false}]
Income Taxes	(33.52K)	(93.00K)	18.00K	[{"date":"2022-12-31","value":-186.22,"profit":false},{"date":"2023-12-31","value":-516.68,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	(39.75M)	(83.89M)	(182.15M)	[{"date":"2022-12-31","value":-3975148000,"profit":false},{"date":"2023-12-31","value":-8389199700,"profit":false},{"date":"2024-12-31","value":-18214600000,"profit":false}]

Income From Continuous Operations	(39.78M)	(83.98M)	(182.15M)	[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-8398500000,"profit":false},{"date":"2024-12-31","value":-18214600000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(39.78M)	(83.98M)	(182.15M)	[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-8398500000,"profit":false},{"date":"2024-12-31","value":-18214600000,"profit":false}]

EPS (Diluted)	-	(6.99)	(3.28)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-699,"profit":false},{"date":"2024-12-31","value":-328.31,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	202.68%	133.19%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":65.71,"profit":true}]
Operating Income	-	202.68%	133.19%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":65.71,"profit":true}]
Total Non-Operating Income/Expense	-	(199.56%)	285.25%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-69.96,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	-	111.10%	116.86%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":95.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	177.46%	(119.35%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-67.26,"profit":false}]
Income After Taxes	-	111.04%	117.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":94.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	111.10%	116.88%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":95.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	111.10%	116.88%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":95.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	(53.03%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	130.00K	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	48.00K	-	207.00K	400.00K	400.00K	[{"date":"2024-09-30","value":12,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":51.75,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	(48.00K)	65.00K	(207.00K)	(400.00K)	(400.00K)	[{"date":"2024-09-30","value":-73.85,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-318.46,"profit":false},{"date":"2025-06-30","value":-615.38,"profit":false},{"date":"2025-09-30","value":-615.38,"profit":false}]
Gross Margin	-	50.00%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	58.69M	75.88M	63.10M	73.17M	70.88M	[{"date":"2024-09-30","value":77.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":83.15,"profit":true},{"date":"2025-06-30","value":96.42,"profit":true},{"date":"2025-09-30","value":93.41,"profit":true}]
Operating Income	(58.69M)	(75.88M)	(63.10M)	(73.17M)	(71.28M)	[{"date":"2024-09-30","value":-5868600000,"profit":false},{"date":"2024-12-31","value":-7588100000,"profit":false},{"date":"2025-03-31","value":-6309600000,"profit":false},{"date":"2025-06-30","value":-7316500000,"profit":false},{"date":"2025-09-30","value":-7127800000,"profit":false}]
Total Non-Operating Income/Expense	19.34M	17.36M	15.68M	14.28M	12.64M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":89.79,"profit":true},{"date":"2025-03-31","value":81.09,"profit":true},{"date":"2025-06-30","value":73.86,"profit":true},{"date":"2025-09-30","value":65.35,"profit":true}]
Pre-Tax Income	(49.02M)	(67.20M)	(55.26M)	(66.02M)	(64.96M)	[{"date":"2024-09-30","value":-4901800000,"profit":false},{"date":"2024-12-31","value":-6720000000,"profit":false},{"date":"2025-03-31","value":-5525600000,"profit":false},{"date":"2025-06-30","value":-6602400000,"profit":false},{"date":"2025-09-30","value":-6495999900,"profit":false}]
Income Taxes	-	18.00K	83.00K	72.00K	61.00K	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":21.69,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":86.75,"profit":true},{"date":"2025-09-30","value":73.49,"profit":true}]
Income After Taxes	-	(67.22M)	(55.34M)	(66.10M)	(65.02M)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6721800000,"profit":false},{"date":"2025-03-31","value":-5533900000,"profit":false},{"date":"2025-06-30","value":-6609600000,"profit":false},{"date":"2025-09-30","value":-6502099900,"profit":false}]

Income From Continuous Operations	(49.02M)	(67.22M)	(55.34M)	(66.10M)	(65.02M)	[{"date":"2024-09-30","value":-4901800000,"profit":false},{"date":"2024-12-31","value":-6721800000,"profit":false},{"date":"2025-03-31","value":-5533900000,"profit":false},{"date":"2025-06-30","value":-6609600000,"profit":false},{"date":"2025-09-30","value":-6502100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(49.02M)	(67.22M)	(55.34M)	(66.10M)	(65.02M)	[{"date":"2024-09-30","value":-4901800000,"profit":false},{"date":"2024-12-31","value":-6721800000,"profit":false},{"date":"2025-03-31","value":-5533900000,"profit":false},{"date":"2025-06-30","value":-6609600000,"profit":false},{"date":"2025-09-30","value":-6502100000,"profit":false}]

EPS (Diluted)	(0.86)	(1.18)	(0.95)	(1.13)	(1.11)	[{"date":"2024-09-30","value":-86.31,"profit":false},{"date":"2024-12-31","value":-118,"profit":false},{"date":"2025-03-31","value":-95,"profit":false},{"date":"2025-06-30","value":-113,"profit":false},{"date":"2025-09-30","value":-111,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	93.24%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	(235.42%)	(418.46%)	93.24%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-252.49,"profit":false},{"date":"2025-03-31","value":-448.82,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	29.30%	(16.85%)	15.96%	(3.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-57.5,"profit":false},{"date":"2025-06-30","value":54.46,"profit":true},{"date":"2025-09-30","value":-10.67,"profit":false}]
Operating Income	-	29.30%	(16.85%)	15.96%	(2.58%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-57.5,"profit":false},{"date":"2025-06-30","value":54.46,"profit":true},{"date":"2025-09-30","value":-8.8,"profit":false}]
Total Non-Operating Income/Expense	-	(10.21%)	(9.69%)	(8.92%)	(11.52%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Pre-Tax Income	-	37.09%	(17.77%)	19.49%	(1.61%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.92,"profit":false},{"date":"2025-06-30","value":52.54,"profit":true},{"date":"2025-09-30","value":-4.34,"profit":false}]
Income Taxes	-	-	361.11%	(13.25%)	(15.28%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-3.67,"profit":false},{"date":"2025-09-30","value":-4.23,"profit":false}]
Income After Taxes	-	-	(17.67%)	19.44%	(1.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-90.91,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-8.37,"profit":false}]

Income From Continuous Operations	-	37.13%	(17.67%)	19.44%	(1.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.6,"profit":false},{"date":"2025-06-30","value":52.35,"profit":true},{"date":"2025-09-30","value":-4.38,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	37.13%	(17.67%)	19.44%	(1.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.6,"profit":false},{"date":"2025-06-30","value":52.35,"profit":true},{"date":"2025-09-30","value":-4.38,"profit":false}]

EPS (Diluted)	-	36.72%	(19.49%)	18.95%	(1.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-53.09,"profit":false},{"date":"2025-06-30","value":51.6,"profit":true},{"date":"2025-09-30","value":-4.82,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	152.06M	398.41M	529.71M	[{"date":"2022-12-31","value":28.71,"profit":true},{"date":"2023-12-31","value":75.21,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	3.00M	224.24M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":1.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	152.06M	401.40M	753.95M	[{"date":"2022-12-31","value":20.17,"profit":true},{"date":"2023-12-31","value":53.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	9.98M	20.56M	28.56M	[{"date":"2022-12-31","value":34.94,"profit":true},{"date":"2023-12-31","value":71.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	933.00K	8.60M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":10.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	9.98M	21.49M	37.16M	[{"date":"2022-12-31","value":26.86,"profit":true},{"date":"2023-12-31","value":57.84,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	2.25M	-	1.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":0.04,"profit":true}]
Retained Earnings	(39.78M)	(123.77M)	(305.92M)	[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-12377000000,"profit":false},{"date":"2024-12-31","value":-30591600000,"profit":false}]
Other Stockholders' Equity	257.04M	503.35M	1.02B	[{"date":"2022-12-31","value":25.16,"profit":true},{"date":"2023-12-31","value":49.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	142.07M	379.91M	716.79M	[{"date":"2022-12-31","value":19.82,"profit":true},{"date":"2023-12-31","value":53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	152.06M	401.40M	753.95M	[{"date":"2022-12-31","value":20.17,"profit":true},{"date":"2023-12-31","value":53.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	162.02%	32.96%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":20.34,"profit":true}]
Non-current Assets	-	-	7387.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	163.99%	87.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":53.56,"profit":true}]

Total Liabilities
Current Liabilities	-	105.99%	38.92%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":36.72,"profit":true}]
Non-current Liabilities	-	-	821.44%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	115.34%	72.90%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":63.2,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	211.10%	147.16%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":69.71,"profit":true}]
Other Stockholders' Equity	-	95.83%	103.00%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":93.04,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	167.40%	88.67%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":52.97,"profit":true}]

Total Liabilities & Shareholders Equity	-	163.99%	87.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":53.56,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	534.48M	529.71M	521.53M	516.12M	540.10M	[{"date":"2024-09-30","value":98.96,"profit":true},{"date":"2024-12-31","value":98.08,"profit":true},{"date":"2025-03-31","value":96.56,"profit":true},{"date":"2025-06-30","value":95.56,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	241.80M	224.24M	192.63M	141.65M	86.06M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":92.74,"profit":true},{"date":"2025-03-31","value":79.66,"profit":true},{"date":"2025-06-30","value":58.58,"profit":true},{"date":"2025-09-30","value":35.59,"profit":true}]
Total Assets	776.29M	753.95M	714.16M	657.77M	626.16M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.12,"profit":true},{"date":"2025-03-31","value":92,"profit":true},{"date":"2025-06-30","value":84.73,"profit":true},{"date":"2025-09-30","value":80.66,"profit":true}]

Total Liabilities
Current Liabilities	32.61M	28.56M	32.96M	31.55M	34.05M	[{"date":"2024-09-30","value":95.78,"profit":true},{"date":"2024-12-31","value":83.88,"profit":true},{"date":"2025-03-31","value":96.81,"profit":true},{"date":"2025-06-30","value":92.67,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	9.27M	8.60M	7.84M	6.82M	5.77M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":92.71,"profit":true},{"date":"2025-03-31","value":84.55,"profit":true},{"date":"2025-06-30","value":73.55,"profit":true},{"date":"2025-09-30","value":62.27,"profit":true}]
Total Liabilities	41.88M	37.16M	40.80M	38.37M	39.82M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":88.71,"profit":true},{"date":"2025-03-31","value":97.41,"profit":true},{"date":"2025-06-30","value":91.61,"profit":true},{"date":"2025-09-30","value":95.07,"profit":true}]

Total Shareholders' equity
Common Stock	1.00K	1.00K	1.00K	1.00K	1.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(238.70M)	(305.92M)	(361.25M)	(427.35M)	(492.37M)	[{"date":"2024-09-30","value":-23869800000,"profit":false},{"date":"2024-12-31","value":-30591600000,"profit":false},{"date":"2025-03-31","value":-36125500000,"profit":false},{"date":"2025-06-30","value":-42735100000,"profit":false},{"date":"2025-09-30","value":-49237200000,"profit":false}]
Other Stockholders' Equity	969.83M	1.02B	1.03B	1.05B	1.08B	[{"date":"2024-09-30","value":89.99,"profit":true},{"date":"2024-12-31","value":94.81,"profit":true},{"date":"2025-03-31","value":95.9,"profit":true},{"date":"2025-06-30","value":97.07,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	734.40M	716.79M	673.36M	619.40M	586.34M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.6,"profit":true},{"date":"2025-03-31","value":91.69,"profit":true},{"date":"2025-06-30","value":84.34,"profit":true},{"date":"2025-09-30","value":79.84,"profit":true}]

Total Liabilities & Shareholders Equity	776.29M	753.95M	714.16M	657.77M	626.16M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.12,"profit":true},{"date":"2025-03-31","value":92,"profit":true},{"date":"2025-06-30","value":84.73,"profit":true},{"date":"2025-09-30","value":80.66,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(0.89%)	(1.54%)	(1.04%)	4.65%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-19.21,"profit":false},{"date":"2025-03-31","value":-33.25,"profit":false},{"date":"2025-06-30","value":-22.33,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	(7.26%)	(14.10%)	(26.47%)	(39.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(2.88%)	(5.28%)	(7.90%)	(4.81%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(12.42%)	15.41%	(4.27%)	7.91%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-80.63,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-27.75,"profit":false},{"date":"2025-09-30","value":51.35,"profit":true}]
Non-current Liabilities	-	(7.29%)	(8.81%)	(13.01%)	(15.34%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Liabilities	-	(11.29%)	9.80%	(5.95%)	3.78%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-115.11,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-60.72,"profit":false},{"date":"2025-09-30","value":38.54,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	28.16%	18.09%	18.30%	15.21%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":64.24,"profit":true},{"date":"2025-06-30","value":64.97,"profit":true},{"date":"2025-09-30","value":54.03,"profit":true}]
Other Stockholders' Equity	-	5.36%	1.15%	1.21%	3.02%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":21.46,"profit":true},{"date":"2025-06-30","value":22.62,"profit":true},{"date":"2025-09-30","value":56.41,"profit":true}]
Total Shareholders' equity	-	(2.40%)	(6.06%)	(8.01%)	(5.34%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(2.88%)	(5.28%)	(7.90%)	(4.81%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(16.43M)	(74.76M)	(171.17M)	[{"date":"2022-12-31","value":-1642700000,"profit":false},{"date":"2023-12-31","value":-7476100000,"profit":false},{"date":"2024-12-31","value":-17117400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(273.91M)	(300.46M)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-27391000000,"profit":false},{"date":"2024-12-31","value":-30046200000,"profit":false}]

Financing Activities
Net Financing Cash Flow	168.32M	315.39M	495.11M	[{"date":"2022-12-31","value":34,"profit":true},{"date":"2023-12-31","value":63.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	151.89M	(33.28M)	23.47M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-21.91,"profit":false},{"date":"2024-12-31","value":15.45,"profit":true}]

Free Cash Flow
Free Cash Flow	(16.43M)	(74.93M)	(172.33M)	[{"date":"2022-12-31","value":-1642700000,"profit":false},{"date":"2023-12-31","value":-7492800000,"profit":false},{"date":"2024-12-31","value":-17232600000,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	355.11%	128.96%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":36.32,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	9.69%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	87.38%	56.98%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":65.21,"profit":true}]

Net Change in Cash	-	(121.91%)	(170.53%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	356.13%	129.99%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":36.5,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(42.52M)	(67.71M)	(48.48M)	(62.03M)	(54.26M)	[{"date":"2024-09-30","value":-4252400000,"profit":false},{"date":"2024-12-31","value":-6771400000,"profit":false},{"date":"2025-03-31","value":-4847700000,"profit":false},{"date":"2025-06-30","value":-6202900000,"profit":false},{"date":"2025-09-30","value":-5425500000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(146.38M)	46.37M	12.98M	78.13M	17.95M	[{"date":"2024-09-30","value":-187.36,"profit":false},{"date":"2024-12-31","value":59.35,"profit":true},{"date":"2025-03-31","value":16.62,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":22.97,"profit":true}]

Financing Activities
Net Financing Cash Flow	383.00K	44.36M	622.00K	1.18M	19.74M	[{"date":"2024-09-30","value":0.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":1.4,"profit":true},{"date":"2025-06-30","value":2.66,"profit":true},{"date":"2025-09-30","value":44.5,"profit":true}]

Net Change in Cash	(188.52M)	23.01M	(34.87M)	17.28M	(16.57M)	[{"date":"2024-09-30","value":-819.33,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-151.56,"profit":false},{"date":"2025-06-30","value":75.08,"profit":true},{"date":"2025-09-30","value":-72.02,"profit":false}]

Free Cash Flow
Free Cash Flow	(43.27M)	(67.72M)	(52.79M)	(62.80M)	(54.26M)	[{"date":"2024-09-30","value":-4327500000,"profit":false},{"date":"2024-12-31","value":-6771500000,"profit":false},{"date":"2025-03-31","value":-5279400000,"profit":false},{"date":"2025-06-30","value":-6279700000,"profit":false},{"date":"2025-09-30","value":-5425500000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	59.24%	(28.41%)	27.96%	(12.53%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.96,"profit":false},{"date":"2025-06-30","value":47.19,"profit":true},{"date":"2025-09-30","value":-21.16,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(131.68%)	(72.00%)	501.79%	(77.03%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26.24,"profit":false},{"date":"2025-03-31","value":-14.35,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-15.35,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	11481.20%	(98.60%)	89.71%	1572.71%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-0.86,"profit":false},{"date":"2025-06-30","value":0.78,"profit":true},{"date":"2025-09-30","value":13.7,"profit":true}]

Net Change in Cash	-	(112.21%)	(251.56%)	(149.54%)	(195.92%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	56.48%	(22.03%)	18.95%	(13.60%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-39.02,"profit":false},{"date":"2025-06-30","value":33.55,"profit":true},{"date":"2025-09-30","value":-24.09,"profit":false}]

Apogee Therapeutics, Inc. Common Stock Ratios

Apogee Therapeutics, Inc. Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	APGE
Cash Ratio	15.49
Current Ratio	15.86

Apogee Therapeutics, Inc. Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	APGE
ROA (LTM)	-25.26%
ROE (LTM)	-38.41%

Apogee Therapeutics, Inc. Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	APGE
Debt Ratio Lower is generally better. Negative is bad.	0.06
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.94

Apogee Therapeutics, Inc. Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	APGE
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	7.89
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Apogee Therapeutics, Inc. Common Stock share price today?

Apogee Therapeutics, Inc. Common Stock (APGE) share price today is $68.93

Can Indians buy Apogee Therapeutics, Inc. Common Stock shares?

Yes, Indians can buy shares of Apogee Therapeutics, Inc. Common Stock (APGE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in APGE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Apogee Therapeutics, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Apogee Therapeutics, Inc. Common Stock (APGE) via the Vested app. You can start investing in Apogee Therapeutics, Inc. Common Stock (APGE) with a minimum investment of $1.

How to invest in Apogee Therapeutics, Inc. Common Stock shares from India?

You can invest in shares of Apogee Therapeutics, Inc. Common Stock (APGE) via Vested in three simple steps:

Click on Sign Up or Invest in APGE stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Apogee Therapeutics, Inc. Common Stock shares

What is Apogee Therapeutics, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Apogee Therapeutics, Inc. Common Stock (APGE) is $84.56. The 52-week low price of Apogee Therapeutics, Inc. Common Stock (APGE) is $26.2.

What is Apogee Therapeutics, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Apogee Therapeutics, Inc. Common Stock (APGE) is

What is Apogee Therapeutics, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Apogee Therapeutics, Inc. Common Stock (APGE) is 7.89

What is Apogee Therapeutics, Inc. Common Stock dividend yield?

The dividend yield of Apogee Therapeutics, Inc. Common Stock (APGE) is 0.00%

What is the Market Cap of Apogee Therapeutics, Inc. Common Stock?

The market capitalization of Apogee Therapeutics, Inc. Common Stock (APGE) is $4.80B

What is Apogee Therapeutics, Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Apogee Therapeutics, Inc. Common Stock is APGE

How Can Investors Use Apogee Therapeutics, Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Apogee Therapeutics, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Apogee Therapeutics, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Apogee Therapeutics, Inc. Common Stock shares for Indian investors?

When investing in Apogee Therapeutics, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Apogee Therapeutics, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Apogee Therapeutics, Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Apogee Therapeutics, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Apogee Therapeutics, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Apogee Therapeutics, Inc. Common Stock Share Price

Apogee Therapeutics, Inc. Common Stock Analyst Forecast

Apogee Therapeutics, Inc. Common Stock Share Price Chart

Apogee Therapeutics, Inc. Common Stock Key Stock Metrics

About Apogee Therapeutics, Inc. Common Stock, Common Stock

Apogee Therapeutics, Inc. Common Stock Stock Returns

Apogee Therapeutics, Inc. Common Stock Financials

Apogee Therapeutics, Inc. Common Stock Ratios

Apogee Therapeutics, Inc. Common Stock Liquidity Ratios

Apogee Therapeutics, Inc. Common Stock Asset Efficiency Ratios

Apogee Therapeutics, Inc. Common Stock Liability Ratios

Apogee Therapeutics, Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Apogee Therapeutics, Inc. Common Stock Share Price

Apogee Therapeutics, Inc. Common Stock Analyst Forecast

Apogee Therapeutics, Inc. Common Stock Share Price Chart

Apogee Therapeutics, Inc. Common Stock Key Stock Metrics

About Apogee Therapeutics, Inc. Common Stock, Common Stock

Apogee Therapeutics, Inc. Common Stock Stock Returns

Apogee Therapeutics, Inc. Common Stock Financials

Apogee Therapeutics, Inc. Common Stock Ratios

Apogee Therapeutics, Inc. Common Stock Liquidity Ratios

Apogee Therapeutics, Inc. Common Stock Asset Efficiency Ratios

Apogee Therapeutics, Inc. Common Stock Liability Ratios

Apogee Therapeutics, Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²